FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Top News
Detained in Myanmar
North Korea
Reuters Investigates
Tech
The Wider Image
The Road to Brexit
Syria
Sports
Commentary
Pictures
Markets News
February 7, 2018 / 12:13 PM / 3 months ago

BRIEF-India's Aurobindo Pharma Dec-Qtr Consol Net Profit Rises About 3 Pct

Reuters Staff

1 Min Read

Feb 7 (Reuters) - Aurobindo Pharma Ltd:

* DEC QUARTER CONSOL NET PROFIT 5.95 BILLION RUPEES VERSUS 5.79 BILLION RUPEES LAST YEAR

* CONSENSUS FORECAST FOR DEC QUARTER CONSOL NET PROFIT WAS 6.71 BILLION RUPEES

* DEC QUARTER CONSOL NET SALES 42.69 BILLION RUPEES VERSUS 38.44 BILLION RUPEES LAST YEAR Source text: bit.ly/2BhpC5Y Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.